Review
Psoralen photochemotherapy
Affiliations
- PMID: 9460332
Item in Clipboard
Review
Psoralen photochemotherapy
Dermatol Nurs.
1997 Dec.
Abstract
Psoralens and sunlight have been used by the Egyptians and Indians for hundreds of years for treating vitiligo. The combination of oral psoralens and artificial ultraviolet A (PUVA) therapy was approved for managing severe psoriasis by the Food and Drug Administration in 1982. Since then, PUVA therapy has been an effective modality for treating many cutaneous conditions (psoriasis, atopic dermatitis, vitiligo, and mycosis fungoides). However, proper knowledge and administration of PUVA therapy are vital to treatment success and reducing side effects.
Similar articles
-
Psoralen photochemotherapy.J Am Acad Dermatol. 1987 Nov;17(5 Pt 1):703-34. doi: 10.1016/s0190-9622(87)70255-2. J Am Acad Dermatol. 1987. PMID: 3316316 Review.
-
The Science and (Lost) Art of Psoralen Plus UVA Phototherapy.Dermatol Clin. 2020 Jan;38(1):11-23. doi: 10.1016/j.det.2019.08.002. Epub 2019 Oct 18. Dermatol Clin. 2020. PMID: 31753184 Review.
-
Treatment of cutaneous sarcoid with topical gel psoralen and ultraviolet A.Br J Dermatol. 2011 Apr;164(4):892-4. doi: 10.1111/j.1365-2133.2010.10175.x. Br J Dermatol. 2011. PMID: 21143466 No abstract available.
-
Photochemotherapy beyond psoriasis.J Am Acad Dermatol. 1994 Nov;31(5 Pt 1):775-90. doi: 10.1016/s0190-9622(94)70240-3. J Am Acad Dermatol. 1994. PMID: 7929924 Review.
-
Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with fitzpatrick skin type IV.Int J Dermatol. 2000 Nov;39(11):865-7. doi: 10.1046/j.1365-4362.2000.00913.x. Int J Dermatol. 2000. PMID: 11123453 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical